Review of paediatric obesity and non‐alcoholic fatty liver disease—A focus on emerging non‐pharmacologic treatment strategies
Pediatric Obesity · 2023
DOI: 10.1111/ijpo.13067 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Obesity, 2023. Verfasst von Travis L Piester und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Gastroenterology, Seattle Children's Hospital, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Pediatric Obesity, Non-alcoholic Fatty Liver Disease, Bariatric Surgery. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 94 Literaturangaben.
Abstract (Originalsprache)
Obesity in paediatrics has become one of the most serious public health concerns worldwide. Paediatric obesity leads to increased adult obesity and is associated with several comorbidities, both physical and psychological. Within gastroenterology, non‐alcoholic fatty liver disease (NAFLD) is now the most common cause of paediatric liver disease and the most common cause of liver transplantation in young adults. Treatment for NAFLD largely focuses on treatment of obesity with weight loss strategies. Unfortunately, the traditional method of weight loss using multicomponent lifestyle modification (dietary changes, increased exercise and behavioural modification) has often led to disappointing results. In adult patients with obesity, treatment strategies have evolved to include bariatric surgery and, more recently, bariatric endoscopy. In paediatrics, the obesity and NAFLD epidemics will likely require this variety of treatment to address children in a personalized manner. Here, we present a review of paediatric obesity, paediatric NAFLD and the various treatment strategies to date. We focus on non‐pharmacologic and emerging therapies, including bariatric surgery and bariatric endoscopy‐based treatments. With such a large population of children and adolescents with obesity, further development of these treatments, including paediatric‐focused clinical trials, is essential for these emerging modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Gastroenterology, Seattle Children's Hospital, Seattle, Washington, USA.
- Department of Medical Gastroenterology and Hepatology, Asian Institute of Gastroenterology, Hyderabad, India.
ORCID-Profile: Travis L Piester
Zitieren
APA
Piester, T. L., Jagtap, N., & Kalapala, R. (2023). Review of paediatric obesity and non‐alcoholic fatty liver disease—A focus on emerging non‐pharmacologic treatment strategies. Pediatric Obesity. https://doi.org/10.1111/ijpo.13067
Vancouver
Piester TL, Jagtap N, Kalapala R. Review of paediatric obesity and non‐alcoholic fatty liver disease—A focus on emerging non‐pharmacologic treatment strategies. Pediatric Obesity. 2023. doi:10.1111/ijpo.13067
BibTeX
@article{Piester2023,
author = {Piester, Travis L and Jagtap, Nitin and Kalapala, Rakesh},
title = {Review of paediatric obesity and non‐alcoholic fatty liver disease—A focus on emerging non‐pharmacologic treatment strategies},
journal = {Pediatric Obesity},
year = {2023},
doi = {10.1111/ijpo.13067}
}
EUVIMED